A Drug Benefitting Families With Fragile X And Autism Is Discontinued | Biosciencia News | Scoop.it

For Holly Roo, mother of a child with fragile X syndrome, the drug arbaclofen allowed her son Parker to accomplish the unimaginable: express himself. But after more than 3 years of trials, Seaside Therapeutics, the drug's sole manufacturer discontinued the drug, leaving the Roos and other families dependent on arbaclofen at a loss.